345(top 1%)
PR articles
23.5K(top 1%)
PR citations
88(top 0.1%)
PR h-index
102(top 0.1%)
h-index
366
documents
31.2K
doc citations
3.5K
citing journals
100
times ranked
awards

Publications

345 peer-reviewed articles • 24,672 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Low oxytocin levels are broadly associated with more pronounced psychopathology in anorexia nervosa with primarily restricting but not binge/purge eating behavior
Frontiers in Endocrinology, 2023, 13, 1049541
2.87Citations (PDF)
2The effect of short-term high-caloric feeding and fasting on bone microarchitecture
Bone, 2022, 154, 116214
2.36Citations (PDF)
3Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa
Nutrients, 2022, 14, 2557
3.211Citations (PDF)
4Changes in marrow adipose tissue in relation to changes in bone parameters following estradiol replacement in adolescent and young adult females with functional hypothalamic amenorrhea
Bone, 2021, 145, 115841
2.311Citations (PDF)
5A cross–nearest neighbor/Monte Carlo algorithm for single molecule localization microscopy defines interactions between p53, Mdm2, and MEG32.30Citations (PDF)
6Bone marrow adipose tissue composition following high-caloric feeding and fasting
Bone, 2021, 152, 116093
2.323Citations (PDF)
7The dynamics of human bone marrow adipose tissue in response to feeding and fasting3.755Citations (PDF)
8Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial3.317Citations (PDF)
9A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG31.39Citations (PDF)
10Modulation of neural fMRI responses to visual food cues by overeating and fasting interventions: A preliminary study
Physiological Reports, 2021, 8, e14639
1.111Citations (PDF)
11Proton Stereotactic Radiotherapy for Treatment of Nelson's Syndrome1.40Citations (PDF)
12Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial3.372Citations (PDF)
13MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands
Pituitary, 2020, 23, 212-222
2.024Citations (PDF)
14Impact of BDNF and sex on maintaining intact memory function in early midlife
Neurobiology of Aging, 2020, 88, 137-149
2.529Citations (PDF)
15SAT-167 Dehydroepiandrosterone Sulfate (DHEAS) Levels Predict Weight Gain in Women with Anorexia Nervosa0.20Citations (PDF)
16Accuracy of Laboratory Tests for the Diagnosis of Cushing Syndrome3.392Citations (PDF)
17Red and White Blood Cell Counts Are Associated With Bone Marrow Adipose Tissue, Bone Mineral Density, and Bone Microarchitecture in Premenopausal Women3.338Citations (PDF)
18SUN-350 Bone Marrow Adipose Tissue Is Associated with Fracture Prevalence in Anorexia Nervosa0.21Citations (PDF)
19The interaction between p53 and Mdm2 is independent of MEG3–p53 association
FASEB Journal, 2020, 34, 1
2.30Citations (PDF)
20Divergent associations between ghrelin and neural responsivity to palatable food in hyperphagic and hypophagic depression3.228Citations (PDF)
21Plasma midkine concentrations in healthy children, children with increased and decreased adiposity, and children with short stature
PLoS ONE, 2019, 14, e0224103
1.55Citations (PDF)
22A Randomized Placebo-Controlled Trial of Low-Dose Testosterone Therapy in Women With Anorexia Nervosa3.323Citations (PDF)
23Disrupted Oxytocin-Appetite Signaling in Females With Anorexia Nervosa3.320Citations (PDF)
24Differences in Trabecular Plate and Rod Structure in Premenopausal Women Across the Weight Spectrum3.313Citations (PDF)
25Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder
Clinical Endocrinology, 2019, 90, 789-797
1.544Citations (PDF)
26Endogenous Oxytocin Levels in Relation to Food Intake, Menstrual Phase, and Age in Females.3.331Citations (PDF)
27Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial6.9109Citations (PDF)
28The paradox of marrow adipose tissue in anorexia nervosa
Bone, 2019, 118, 47-52
2.329Citations (PDF)
29MON-335 Phenocopy of Multiple Endocrine Neoplasia Type 1 (MEN1) Due to a Germline Cell Division Cycle 73 (CDC73) Variant0.21Citations (PDF)
30SAT-441 Oxytocin Levels Are Associated with Psychopathology in Restricting but Not Binge-Purge Subtype of Anorexia Nervosa0.21Citations (PDF)
31SAT-442 Endogenous Oxytocin Response to Food Intake in Anorexia Nervosa0.20Citations (PDF)
32Anorexia nervosa and bone0.713Citations (PDF)
33Impaired bone strength estimates at the distal tibia and its determinants in adolescents with anorexia nervosa
Bone, 2018, 106, 61-68
2.360Citations (PDF)
34Effects of Anorexia Nervosa on Bone Metabolism.
Endocrine Reviews, 2018, 39, 895-910
15.669Citations (PDF)
35The circulating metabolome of human starvation3.7155Citations (PDF)
36A Consensus Statement on acromegaly therapeutic outcomes
Nature Reviews Endocrinology, 2018, 14, 552-561
20.1534Citations (PDF)
37Characterization of cyclic Cushing's disease using late night salivary cortisol testing
Clinical Endocrinology, 2018, 89, 336-345
1.521Citations (PDF)
38Reorganization of Functional Networks in Verbal Working Memory Circuitry in Early Midlife: The Impact of Sex and Menopausal Status.
Cerebral Cortex, 2017, 27, 2857-2870
1.963Citations (PDF)
39Sex differences in episodic memory in early midlife: impact of reproductive aging
Menopause, 2017, 24, 400
1.9132Citations (PDF)
40Oxytocin and Its Relationship to Body Composition, Bone Mineral Density, and Hip Geometry Across the Weight Spectrum.3.362Citations (PDF)
41Macronutrient intake associated with weight gain in adolescent girls with anorexia nervosa2.615Citations (PDF)
42Clinical Outcomes and Self-Reported Symptoms in Patients With Acromegaly: An 8-Year Follow-Up of a Lanreotide Study
Endocrine Practice, 2017, 23, 56-65
1.79Citations (PDF)
43Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Pituitary, 2017, 20, 489-498
2.0305Citations (PDF)
44Anorexia Nervosa: Analysis of Trabecular Texture with CT
Radiology, 2017, 283, 178-185
7.020Citations (PDF)
45Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-52.655Citations (PDF)
46Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis
Endocrine, 2017, 59, 39-49
1.834Citations (PDF)
47Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center
Pituitary, 2016, 19, 437-447
2.011Citations (PDF)
48Impact of Sex and Menopausal Status on Episodic Memory Circuitry in Early Midlife
Journal of Neuroscience, 2016, 36, 10163-10173
2.3118Citations (PDF)
49Dopamine Agonists Can Reduce Cystic Prolactinomas.3.354Citations (PDF)
50Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly1.05Citations (PDF)
51Fat Attenuation at CT in Anorexia Nervosa
Radiology, 2016, 279, 151-7
7.016Citations (PDF)
52Serum FGF-21 levels are associated with worsened radial trabecular bone microarchitecture and decreased radial bone strength in women with anorexia nervosa
Bone, 2015, 77, 6-11
2.348Citations (PDF)
53Sex differences, hormones, and fMRI stress response circuitry deficits in psychoses1.436Citations (PDF)
54Predictors of Hypopituitarism in Patients with Traumatic Brain Injury
Journal of Neurotrauma, 2015, 32, 1789-95
2.456Citations (PDF)
55Cortisol Measures Across the Weight Spectrum3.388Citations (PDF)
56Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease3.366Citations (PDF)
57Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line2.068Citations (PDF)
58FGF21 and the late adaptive response to starvation in humans
Journal of Clinical Investigation, 2015, 125, 4601-4611
6.8212Citations (PDF)
59Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma.3.3459Citations (PDF)
60Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa2.6177Citations (PDF)
61Endocrinology of anorexia nervosa in young people1.755Citations (PDF)
62Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa1.460Citations (PDF)
63Bone Metabolism in Anorexia Nervosa4.033Citations (PDF)
64Teriparatide Increases Bone Formation and Bone Mineral Density in Adult Women With Anorexia Nervosa3.3118Citations (PDF)
65Endocrine consequences of anorexia nervosa12.5320Citations (PDF)
66Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma2.088Citations (PDF)
67Marrow fat composition in anorexia nervosa
Bone, 2014, 66, 199-204
2.399Citations (PDF)
68Effects of Recombinant Human Growth Hormone Therapy on Bone Mineral Density in Adults With Growth Hormone Deficiency: A Meta-Analysis3.398Citations (PDF)
69Bone Marrow Adipose Tissue Is an Endocrine Organ that Contributes to Increased Circulating Adiponectin during Caloric Restriction
Cell Metabolism, 2014, 20, 368-375
21.2524Citations (PDF)
70Positive effects of brown adipose tissue on femoral bone structure.
Bone, 2014, 58, 55-8
2.346Citations (PDF)
71Anorexia nervosa and bone metabolism
Bone, 2014, 66, 39-45
2.348Citations (PDF)
7217β-Estradiol Differentially Regulates Stress Circuitry Activity in Healthy and Depressed Women
Neuropsychopharmacology, 2014, 40, 566-576
4.090Citations (PDF)
73The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: Cons
Endocrine, 2014, 48, 79-82
1.821Citations (PDF)
74IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women
Bone, 2013, 53, 336-339
2.326Citations (PDF)
75Marrow fat and bone--new perspectives.3.3400Citations (PDF)
76Traumatic brain injury: effects on the endocrine system.3.35Citations (PDF)
77Central Diabetes Insipidus: A Previously Unreported Side Effect of Temozolomide3.328Citations (PDF)
78Adolescent Girls With Anorexia Nervosa Have Impaired Cortical and Trabecular Microarchitecture and Lower Estimated Bone Strength at the Distal Radius3.3112Citations (PDF)
79Hip Structural Analysis in Adolescent Boys With Anorexia Nervosa and Controls3.347Citations (PDF)
80C-arm CT for histomorphometric evaluation of lumbar spine trabecular microarchitecture: a study on anorexia nervosa patients.
British Journal of Radiology, 2013, 86, 20120451
1.91Citations (PDF)
81Bone Density Characteristics and Major Depressive Disorder in Adolescents
Psychosomatic Medicine, 2013, 75, 117
1.421Citations (PDF)
82Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density
Clinical Endocrinology, 2013, 79, 326-332
1.537Citations (PDF)
83Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study
Pituitary, 2013, 17, 150-156
2.064Citations (PDF)
84The effect of somatostatin analogs on vitamin D and calcium concentrations in patients with acromegaly
Pituitary, 2013, 17, 366-373
2.018Citations (PDF)
85Web server is down Error code 5211.570Citations (PDF)
86Web server is down Error code 5211.556Citations (PDF)
87Young women with cold-activated brown adipose tissue have higher bone mineral density and lower Pref-1 than women without brown adipose tissue: a study in women with anorexia nervosa, women recovered from anorexia nervosa, and normal-weight women.3.3106Citations (PDF)
88Oxytocin secretion is associated with severity of disordered eating psychopathology and insular cortex hypoactivation in anorexia nervosa.3.3114Citations (PDF)
89Transsphenoidal surgery for cushing disease after nondiagnostic inferior petrosal sinus sampling.
Neurosurgery, 2012, 71, 14-22
1.935Citations (PDF)
90Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly
Clinical Endocrinology, 2012, 77, 430-438
1.536Citations (PDF)
91Neuroendocrine dysregulation and the growth hormone–IGF-1 axis in anorexia nervosa1.72Citations (PDF)
92Brain hypoactivation, autonomic nervous system dysregulation, and gonadal hormones in depression: A preliminary study
Neuroscience Letters, 2012, 514, 57-61
1.345Citations (PDF)
93Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls
Bone, 2012, 51, 474-479
2.344Citations (PDF)
94Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa3.3112Citations (PDF)
95Food motivation circuitry hypoactivation related to hedonic and nonhedonic aspects of hunger and satiety in women with active anorexia nervosa and weight-restored women with anorexia nervosa2.0159Citations (PDF)
96Cortical microstructure and estimated bone strength in young amenorrheic athletes, eumenorrheic athletes and non-athletes
Bone, 2012, 51, 680-687
2.3138Citations (PDF)
97Body Composition and Skeletal Health: Too Heavy? Too Thin?
Current Osteoporosis Reports, 2012, 10, 208-216
4.032Citations (PDF)
98Effect of Growth Hormone Replacement Therapy on the Quality of Life In Women with Growth Hormone Deficiency who Have A History of Acromegaly Versus Other Disorders
Endocrine Practice, 2012, 18, 209-218
1.718Citations (PDF)
99Psychotropic medication use in anorexia nervosa between 1997 and 20092.644Citations (PDF)
100Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat
Clinical Endocrinology, 2012, 76, 520-525
1.5127Citations (PDF)
101Effects of recombinant human growth hormone therapy in adults with Prader–Willi syndrome: a meta-analysis
Clinical Endocrinology, 2012, 77, 86-93
1.583Citations (PDF)
102Pathologic and clinical features of pituitary adenomas showing TSH immunoreactivity
Pituitary, 2012, 16, 287-293
2.016Citations (PDF)
103Plasma sodium level is associated with bone loss severity in women with anorexia nervosa: a cross-sectional study.
Journal of Clinical Psychiatry, 2012, 73, e1379-83
1.517Citations (PDF)
104Bone metabolism in adolescents with anorexia nervosa2.146Citations (PDF)
105Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
American Journal of Pathology, 2011, 179, 2120-2130
2.892Citations (PDF)
106Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass.1.5120Citations (PDF)
107Growth hormone is positively associated with surrogate markers of bone turnover during puberty
Clinical Endocrinology, 2011, 75, 482-488
1.521Citations (PDF)
108Vertebral Bone Marrow Fat Is Positively Associated With Visceral Fat and Inversely Associated With IGF-1 in Obese Women
Obesity, 2011, 19, 49-53
2.9320Citations (PDF)
109Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression
Journal of Affective Disorders, 2011, 131, 379-387
3.294Citations (PDF)
110Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa3.3333Citations (PDF)
111Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: a randomized, placebo-controlled study.3.3154Citations (PDF)
112Bone health in anorexia nervosa1.784Citations (PDF)
113Hyperprolactinemia3.31Citations (PDF)
114Hiperprolactinemia3.30Citations (PDF)
115Comparison of DXA and CT in the Assessment of Body Composition in Premenopausal Women With Obesity and Anorexia Nervosa
Obesity, 2010, 18, 2227-2233
2.9189Citations (PDF)
116Delayed Remission after Transsphenoidal Surgery in Patients with Cushing’s Disease3.3154Citations (PDF)
117Maternally Expressed Gene 3, an Imprinted Noncoding RNA Gene, Is Associated with Meningioma Pathogenesis and Progression
Cancer Research, 2010, 70, 2350-2358
4.2325Citations (PDF)
118Maternally Expressed Gene 3 (MEG3) Noncoding Ribonucleic Acid: Isoform Structure, Expression, and Functions
Endocrinology, 2010, 151, 939-947
1.9326Citations (PDF)
119Visceral Fat Is a Negative Predictor of Bone Density Measures in Obese Adolescent Girls3.3238Citations (PDF)
120Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.3.384Citations (PDF)
121Women with Anorexia Nervosa: Finite Element and Trabecular Structure Analysis by Using Flat-Panel Volume CT
Radiology, 2010, 257, 167-74
7.043Citations (PDF)
122Increased Expression of Angiogenic Genes in the Brains of Mouse Meg3-Null Embryos
Endocrinology, 2010, 151, 2443-2452
1.9156Citations (PDF)
123Peptide YY levels across pubertal stages and associations with growth hormone.3.324Citations (PDF)
124Effects of Recombinant Human Growth Hormone in Anorexia Nervosa: A Randomized, Placebo-Controlled Study3.3111Citations (PDF)
125Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa.3.394Citations (PDF)
126Waist to hip ratio and trunk to extremity fat (DXA) are better surrogates for IMCL and for visceral fat respectively than for subcutaneous fat in adolescent girls2.039Citations (PDF)
127Isolation and characterization of novel pituitary tumor related genes: A cDNA representational difference approach2.026Citations (PDF)
128Growth hormone status predicts left ventricular mass in patients after cure of acromegaly1.015Citations (PDF)
129Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosa
Bone, 2010, 46, 796-800
2.337Citations (PDF)
130Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa
Bone, 2010, 46, 458-463
2.3120Citations (PDF)
131Prolactinomas24.4254Citations (PDF)
132A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening20.18Citations (PDF)
133Hypoglycemia from IGF2 Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma
Endocrine Reviews, 2009, 30, 413-413
15.60Citations (PDF)
134Concomitant Medication Use Can Confound Interpretation of the Combined Dexamethasone-Corticotropin Releasing Hormone Test in Cushing’s Syndrome3.378Citations (PDF)
135Relative Growth Hormone Deficiency and Cortisol Excess Are Associated with Increased Cardiovascular Risk Markers in Obese Adolescent Girls3.322Citations (PDF)
136Hypercortisolemia Is Associated with Severity of Bone Loss and Depression in Hypothalamic Amenorrhea and Anorexia Nervosa3.3151Citations (PDF)
137Increased Bone Marrow Fat in Anorexia Nervosa3.3376Citations (PDF)
138Adrenal glucocorticoid and androgen precursor dissociation in anorexia nervosa.3.339Citations (PDF)
139Dopamine agonist therapy in prolactinomas: when can treatment be discontinued?3.323Citations (PDF)
140Increased Carbohydrate Induced Ghrelin Secretion in Obese vs. Normal-weight Adolescent Girls
Obesity, 2009, 17, 1689-1695
2.930Citations (PDF)
141Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls
Bone, 2009, 45, 104-109
2.387Citations (PDF)
142Effects of rhIGF-1 administration on surrogate markers of bone turnover in adolescents with anorexia nervosa
Bone, 2009, 45, 493-498
2.394Citations (PDF)
143Bone, Fat, and Body Composition: Evolving Concepts in the Pathogenesis of Osteoporosis
American Journal of Medicine, 2009, 122, 409-414
1.6209Citations (PDF)
144Hypoglycemia from IGF2 Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma3.324Citations (PDF)
145Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies1.240Citations (PDF)
146Hypercortisolemia Is Associated with Severity of Bone Loss and Depression in Hypothalamic Amenorrhea and Anorexia Nervosa
Endocrinology, 2009, 150, 5191-5192
1.91Citations (PDF)
147PITUITARY DISORDERS0.70Citations (PDF)
148The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome
Pituitary, 2009, 13, 266-286
2.09Citations (PDF)
149Hypoglycemia from IGF2 Overexpression Associated with Activation of Fetal Promoters and Loss of Imprinting in a Metastatic Hemangiopericytoma
Molecular Endocrinology, 2009, 23, 944-944
3.01Citations (PDF)
150Acylated ghrelin and leptin in adolescent athletes with amenorrhea, eumenorrheic athletes and controls: a cross-sectional study
Clinical Endocrinology, 2008, 69, 628-633
1.584Citations (PDF)
151Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa
Bone, 2008, 43, 135-139
2.3112Citations (PDF)
152Endocrine abnormalities in anorexia nervosa5.993Citations (PDF)
153Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls2.5147Citations (PDF)
154Bone Metabolism in Adolescent Athletes With Amenorrhea, Athletes With Eumenorrhea, and Control Subjects
Pediatrics, 2008, 121, 1127-1136
2.9144Citations (PDF)
155Percentage extremity fat, but not percentage trunk fat, is lower in adolescent boys with anorexia nervosa than in healthy adolescents.3.426Citations (PDF)
156Selective Loss of MEG3 Expression and Intergenic Differentially Methylated Region Hypermethylation in the MEG3/DLK1 Locus in Human Clinically Nonfunctioning Pituitary Adenomas3.3134Citations (PDF)
157Determinants of Height in Adolescent Girls With Anorexia Nervosa
Pediatrics, 2008, 121, e1517-e1523
2.939Citations (PDF)
158Bone Metabolism in Adolescent Boys with Anorexia Nervosa3.3124Citations (PDF)
159Prognostic Indicators of Changes in Bone Density Measures in Adolescent Girls with Anorexia Nervosa-II3.360Citations (PDF)
160Proton Stereotactic Radiotherapy for Persistent Adrenocorticotropin-Producing Adenomas3.3117Citations (PDF)
161Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.3.395Citations (PDF)
162Extensive Clinical Experience:Changing Patterns in Diagnosis and Therapy of Acromegaly over Two Decades3.3129Citations (PDF)
163Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa.3.3174Citations (PDF)
164Hormonal and nutritional effects on cardiovascular risk markers in young women.3.323Citations (PDF)
165Androgens in Women with Anorexia Nervosa and Normal-Weight Women with Hypothalamic Amenorrhea3.3124Citations (PDF)
166Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism.3.336Citations (PDF)
167Growth Hormone Suppression after an Oral Glucose Load in Children3.324Citations (PDF)
168Androgens in Women With Anorexia Nervosa and Normal-Weight Women With Hypothalamic Amenorrhea0.10Citations (PDF)
169Regulation of growth hormone expression by Delta-like protein 1 (Dlk1)2.041Citations (PDF)
170Activation of p53 by MEG3 Non-coding RNA*
Journal of Biological Chemistry, 2007, 282, 24731-24742
1.3629Citations (PDF)
171Proton Stereotactic Radiosurgery in Management of Persistent Acromegaly
Endocrine Practice, 2007, 13, 726-734
1.766Citations (PDF)
172Web server is down Error code 5211.556Citations (PDF)
173Cyclic AMP stimulates gene expression in cells through a cAMP-response element (CRE) in the proximal promoter region2.078Citations (PDF)
174Uncoupling of cardiovascular risk markers in adolescent girls with anorexia nervosa
Journal of Pediatrics, 2006, 149, 763-769.e1
1.747Citations (PDF)
175Cardiovascular Risk in Patients with Growth Hormone Deficiency: Effects of Growth Hormone Substitution
Endocrine Practice, 2006, 12, 682-689
1.719Citations (PDF)
176Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans.
Behavioral Neuroscience, 2006, 120, 1196-203
1.2199Citations (PDF)
177Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents.3.4138Citations (PDF)
178Effects of Testosterone Replacement in Androgen-Deficient Women With Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study0.10Citations (PDF)
179Regional cerebral brain metabolism correlates of neuroticism and extraversion
Depression and Anxiety, 2006, 23, 133-138
1.188Citations (PDF)
180Elevated peptide YY levels in adolescent girls with anorexia nervosa.3.3248Citations (PDF)
181Role of Cortisol in Menstrual Recovery in Adolescent Girls with Anorexia Nervosa
Pediatric Research, 2006, 59, 598-603
1.587Citations (PDF)
182Determinants of Skeletal Loss and Recovery in Anorexia Nervosa3.3241Citations (PDF)
183The effects of SOM230 on cell proliferation and adrenocorticotropin secretion in human corticotroph pituitary adenomas.3.3193Citations (PDF)
184Effects of Testosterone Replacement in Androgen-Deficient Women with Hypopituitarism: A Randomized, Double-Blind, Placebo-Controlled Study3.3221Citations (PDF)
185Case 36-2006 — A 35-Year-Old Pregnant Woman with New Hypertension24.432Citations (PDF)
186Anorexia nervosa and osteoporosis5.194Citations (PDF)
187Web server is down Error code 5211.544Citations (PDF)
188Testosterone Administration in Women With Anorexia Nervosa0.10Citations (PDF)
189Reciprocal changes in endogenous ghrelin and growth hormone during fasting in healthy women2.529Citations (PDF)
190Secretory dynamics of leptin in adolescent girls with anorexia nervosa and healthy adolescents2.5154Citations (PDF)
191Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents2.5157Citations (PDF)
192Medical Findings in Outpatients With Anorexia Nervosa
Archives of Internal Medicine, 2005, 165, 561-566
8.3307Citations (PDF)
193Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.3.356Citations (PDF)
194Ghrelin and Bone Metabolism in Adolescent Girls with Anorexia Nervosa and Healthy Adolescents3.3119Citations (PDF)
195A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly3.3197Citations (PDF)
196Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk.3.385Citations (PDF)
197Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.3.3211Citations (PDF)
198Testosterone administration in women with anorexia nervosa.3.3103Citations (PDF)
199Synergy of activin and ciliary neurotrophic factor signaling pathways in the induction of vasoactive intestinal peptide gene expression.
Molecular Endocrinology, 2004, 14, 429-39
3.07Citations (PDF)
200Hormonal and Body Composition Predictors of Soluble Leptin Receptor, Leptin, and Free Leptin Index in Adolescent Girls with Anorexia Nervosa and Controls and Relation to Insulin Sensitivity3.3131Citations (PDF)
201Effects of estrogen and recombinant human insulin-like growth factor-I on ghrelin secretion in severe undernutrition.3.342Citations (PDF)
202Receptor internalization-independent activation of Smad2 in activin signaling.
Molecular Endocrinology, 2004, 18, 1818-26
3.027Citations (PDF)
203Effects of risedronate on bone density in anorexia nervosa.3.3120Citations (PDF)
204Preservation of neuroendocrine control of reproductive function despite severe undernutrition.3.3161Citations (PDF)
205Diagnostic Errors after Inferior Petrosal Sinus Sampling3.3200Citations (PDF)
206Growth Hormone and Ghrelin Responses to an Oral Glucose Load in Adolescent Girls with Anorexia Nervosa and Controls3.3103Citations (PDF)
207Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism.3.3237Citations (PDF)
208Effects of Anorexia Nervosa on Clinical, Hematologic, Biochemical, and Bone Density Parameters in Community-Dwelling Adolescent Girls
Pediatrics, 2004, 114, 1574-1583
2.9360Citations (PDF)
209Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa1.451Citations (PDF)
210Measurement of Free Testosterone in Normal Women and Women with Androgen Deficiency: Comparison of Methods3.3282Citations (PDF)
211Testosterone administration attenuates regional brain hypometabolism in women with anorexia nervosa1.40Citations (PDF)
212Synergy of Activin and Ciliary Neurotrophic Factor Signaling Pathways in the Induction of Vasoactive Intestinal Peptide Gene Expression
Molecular Endocrinology, 2004, 14, 429-439
3.05Citations (PDF)
213Web server is down Error code 521
Journal of Clinical Psychiatry, 2004, 65, 1607-18; quiz 1590, 1760-1
1.5143Citations (PDF)
214Tumores pituitarios3.30Citations (PDF)
215Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
Psychoneuroendocrinology, 2003, 28, 97-108
1.1104Citations (PDF)
216Growth hormone and cardiovascular risk markers
Growth Hormone and IGF Research, 2003, 13, S109-S115
1.014Citations (PDF)
217Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.3.3489Citations (PDF)
218Effects of Growth Hormone Secretion on Body Composition in Patients with Crohn’s Disease3.330Citations (PDF)
219Alterations in Growth Hormone Secretory Dynamics in Adolescent Girls with Anorexia Nervosa and Effects on Bone Metabolism3.3237Citations (PDF)
220Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.3.339Citations (PDF)
221Serum Osteoprotegerin in Adolescent Girls with Anorexia Nervosa3.388Citations (PDF)
222Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm.3.387Citations (PDF)
223A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells3.3440Citations (PDF)
224Regional body composition in adolescents with anorexia nervosa and changes with weight recovery.3.477Citations (PDF)
225The role of the clinical laboratory in the diagnosis of Cushing syndrome.0.44Citations (PDF)
226Overexpression of Wild-Type Activin Receptor Alk4-1 Restores Activin Antiproliferative Effects in Human Pituitary Tumor Cells3.327Citations (PDF)
227Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.3.3143Citations (PDF)
228Gonadotropinomas1.268Citations (PDF)
229Androgens and bone density in women with hypopituitarism.3.326Citations (PDF)
230Abnormal Bone Mineral Accrual in Adolescent Girls with Anorexia Nervosa3.3369Citations (PDF)
231Effects of Recombinant Human IGF-I and Oral Contraceptive Administration on Bone Density in Anorexia Nervosa3.3330Citations (PDF)
232Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder
Psychiatry Research, 2002, 111, 11-20
2.593Citations (PDF)
233Cardiovascular Risk in Women with Hypopituritarism3.32Citations (PDF)
234Evaluation and Treatment of Low Bone Density in Anorexia Nervosa1.014Citations (PDF)
235Effects of a growth hormone receptor antagonist on bone markers in acromegaly
Clinical Endocrinology, 2002, 57, 385-390
1.534Citations (PDF)
236Current Status and Future Opportunities for Controlling Acromegaly
Pituitary, 2002, 5, 185-196
2.035Citations (PDF)
237Effects of Recombinant Human IGF-I and Oral Contraceptive Administration on Bone Density in Anorexia Nervosa3.384Citations (PDF)
238Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa.3.4106Citations (PDF)
239Prolactin Secreting Pituitary Tumors in Men
The Endocrinologist, 2001, 11, 105
0.16Citations (PDF)
240Regional Osteoporosis in Anorexia Nervosa7.34Citations (PDF)
241Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis1.4197Citations (PDF)
242Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study
Clinical Endocrinology, 2001, 54, 183-188
1.585Citations (PDF)
243Medical Therapy of Prolactinomas in Men3.30Citations (PDF)
244Inflammatory cardiovascular risk markers in women with hypopituitarism.3.395Citations (PDF)
245Osteopenia in Eugonadal Men with Acquired Immune Deficiency Syndrome Wasting Syndrome13.373Citations (PDF)
246Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.3.373Citations (PDF)
247Androgen deficiency in women with hypopituitarism.3.396Citations (PDF)
248Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.3.353Citations (PDF)
249Inflammatory Cardiovascular Risk Markers in Women with Hypopituitarism3.327Citations (PDF)
250Medical Therapy of Prolactinomas in Men3.30Citations (PDF)
251Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial
Annals of Internal Medicine, 2000, 133, 111-22
7.3231Citations (PDF)
252Clinical review 117: Hormonal determinants and disorders of peak bone mass in children.3.3133Citations (PDF)
253Assessment of macronutrient and micronutrient intake in women with anorexia nervosa2.6182Citations (PDF)
254Cardiovascular risk markers in hypothalamic amenorrhoea
Clinical Endocrinology, 2000, 53, 359-366
1.54Citations (PDF)
255Activin effects on neoplastic proliferation of human pituitary tumors.3.346Citations (PDF)
256Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling
Molecular Endocrinology, 2000, 14, 2066-2075
3.050Citations (PDF)
257A human pituitary tumor-derived folliculostellate cell line.3.340Citations (PDF)
258Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.3.393Citations (PDF)
259Primary Medical Therapy of Micro- and Macroprolactinomas in Men*3.3123Citations (PDF)
260Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling
Molecular Endocrinology, 2000, 14, 2066-2075
3.014Citations (PDF)
261Biochemical Assessment in Patients with Cushing’s Disease due to Corticotroph Macroadenomas—Authors’ Response3.30Citations (PDF)
262Severity of Osteopenia in Estrogen-Deficient Women with Anorexia Nervosa and Hypothalamic Amenorrhea13.3182Citations (PDF)
263Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.3.326Citations (PDF)
264Mutational analysis of activin/transforming growth factor-beta type I and type II receptor kinases in human pituitary tumors.3.336Citations (PDF)
265The Effects of Anorexia Nervosa on Bone Metabolism in Female Adolescents13.3267Citations (PDF)
266Clinical review 106: Amenorrheic bone loss.3.378Citations (PDF)
267Eating Disorders24.4425Citations (PDF)
268102 Hypothalamic-pituitary gland dysfunction following high dose conformal mixed proton/photon radiotherapy to the base of skull region: demonstration of a dose effect relationship using dose volume histogram analysis1.40Citations (PDF)
269Prolactin pulsatile characteristics in postmenopausal women.3.358Citations (PDF)
270Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.3.3515Citations (PDF)
271Effects of Physiological Growth Hormone (GH) Therapy on Cognition and Quality of Life in Patients with Adult-Onset GH Deficiency13.3155Citations (PDF)
272Prevention of Estrogen Deficiency–Related Bone Loss With Human Parathyroid Hormone–(1-34): A Randomized Controlled Trial19.5159Citations (PDF)
273Current treatment guidelines for acromegaly.3.3170Citations (PDF)
274Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.3.379Citations (PDF)
275Decreased Leptin Levels in Normal Weight Women with Hypothalamic Amenorrhea: The Effects of Body Composition and Nutritional Intake13.3136Citations (PDF)
276Determinants of increased energy expenditure in HIV-infected women.3.455Citations (PDF)
277Tumor-Specific Expression of Alternatively Spliced Estrogen Receptor Messenger Ribonucleic Acid Variants in Human Pituitary Adenomas*3.343Citations (PDF)
278A decade of the Massachusetts General Hospital Neuroendocrine Clinical Center.3.311Citations (PDF)
279A Decade of the Massachusetts General Hospital Neuroendocrine Clinical Center3.31Citations (PDF)
280Effects of Physiologic Growth Hormone Therapy on Bone Density and Body Composition in Patients with Adult-Onset Growth Hormone Deficiency: A Randomized, Placebo-Controlled Trial
Annals of Internal Medicine, 1996, 125, 883-90
7.3259Citations (PDF)
281A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty.3.3158Citations (PDF)
282Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men--a clinical research center study.3.384Citations (PDF)
283Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.3.3228Citations (PDF)
284Decreased bone formation and increased mineral dissolution during acute fasting in young women.3.383Citations (PDF)
285The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa.3.3378Citations (PDF)
286Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.3.373Citations (PDF)
287The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa3.3310Citations (PDF)
288Effects of rhIGF-I administration on bone turnover during short-term fasting.6.8104Citations (PDF)
289ras mutations in human prolactinomas and pituitary carcinomas.3.397Citations (PDF)
290Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen Deficiency24.4245Citations (PDF)
291The retinoblastoma gene in human pituitary tumors.3.3103Citations (PDF)
292Glycoprotein hormone alpha-subunit production in somatotroph adenomas with and without Gs alpha mutations.3.347Citations (PDF)
293Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.3.3122Citations (PDF)
294Osteopenia in Men with a History of Delayed Puberty24.4444Citations (PDF)
295Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease.3.378Citations (PDF)
296Ras mutations in human pituitary tumors.3.3170Citations (PDF)
297Ricin and lentil lectin-affinity chromatography reveals oligosaccharide heterogeneity of thyrotropin secreted by 12 human pituitary tumors9.037Citations (PDF)
298Effects of chronic GnRH analogue administration on gonadotrophin and α-subunit secretion in post-menopausal women
Clinical Endocrinology, 1992, 36, 559-564
1.513Citations (PDF)
299The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas.3.328Citations (PDF)
300Somatostatin regulation of glycoprotein hormone and free subunit secretion in clinically nonfunctioning and somatotroph adenomas in vitro.3.339Citations (PDF)
301Diagnosis and Management of Hormone-Secreting Pituitary Adenomas24.4144Citations (PDF)
302Further evidence for a somatic mutation theory in the pathogenesis of human pituitary tumors.3.321Citations (PDF)
303Age alters pulsatile prolactin release: influence of dopaminergic inhibition2.519Citations (PDF)
304Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-acting Non-Ergot Dopamine Agonist CV 205-502
Annals of Internal Medicine, 1990, 112, 668-73
7.372Citations (PDF)
305Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea.3.3170Citations (PDF)
306Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas.3.373Citations (PDF)
307Importance of Gonadal Steroids to Bone Mass in Men with Hyperprolactinemic Hypogonadism
Annals of Internal Medicine, 1989, 110, 526-31
7.3176Citations (PDF)
308Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa.3.3420Citations (PDF)
309Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.3.356Citations (PDF)
310Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.3.325Citations (PDF)
311Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.3.3351Citations (PDF)
312Elevated Serum Lipids in Hypogonadal Men with and without Hyperprolactinemia
Annals of Internal Medicine, 1989, 111, 288-92
7.344Citations (PDF)
313Age and bone mass in premenopausal women3.3133Citations (PDF)
314Medical Therapy of Glycoprotein Hormone–Secreting Pituitary tumors2.212Citations (PDF)
315Endocrine function following high dose proton therapy for tumors of the upper clivus1.429Citations (PDF)
316Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal women
Psychoneuroendocrinology, 1988, 13, 273-278
1.114Citations (PDF)
317Effects of prolactin and estrogen deficiency in amenorrheic bone loss.3.3186Citations (PDF)
318Dopaminergic regulation of alpha-subunit secretion and messenger ribonucleic acid levels in alpha-secreting pituitary tumors.3.343Citations (PDF)
319Luteinizing hormone-secreting pituitary tumor: biosynthetic characterization and clinical studies.3.373Citations (PDF)
320Increase in Bone Mass after Treatment of Hyperprolactinemic Amenorrhea0.15Citations (PDF)
321Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
Annals of Internal Medicine, 1987, 106, 354-61
7.3375Citations (PDF)
322Lymphocytic Adenohypophysitis of Pregnancy with Complete Recovery
Neurosurgery, 1987, 20, 791
1.992Citations (PDF)
323Diagnostic Dilemmas in the Management of Hypothalamic-Pituitary-Adrenal Disorders2.65Citations (PDF)
324Nonsecreting Pituitary Tumors2.287Citations (PDF)
325Pituitary function following high dose proton therapy for tumors of the upper clivus1.40Citations (PDF)
326Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.6.8142Citations (PDF)
327Divergent dopaminergic regulation of TSH, free α-subunit, and TSH-β in pituitary cell culture9.06Citations (PDF)
328Osteoporosis in Men with Hyperprolactinemic Hypogonadism
Annals of Internal Medicine, 1986, 104, 777-82
7.3244Citations (PDF)
329Increase in Bone Mass after Treatment of Hyperprolactinemic Amenorrhea24.4207Citations (PDF)
330Pulsatile secretion of thyrotropin in man.3.3156Citations (PDF)
331Prolactin response to thyrotropin-releasing hormone (TRH) in patients with hypothalamic-pituitary disease
Fertility and Sterility, 1985, 43, 66-73
2.317Citations (PDF)
332Catecholestrogen regulation of prolactin synthesis in pituitary cell culture.
Endocrinology, 1985, 117, 939-46
1.97Citations (PDF)
333Effect of carbohydrate supplementation on reproductive hormones during fasting in men.3.319Citations (PDF)
334Hormonal responses to short term fasting in postmenopausal women.3.351Citations (PDF)
335Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.3.357Citations (PDF)
336Osteoporosis and Hyperprolactinemia1.68Citations (PDF)
337DOPAMINERGIC MODULATION OF TSH AND ITS SUBUNITS: IN VIVO AND IN VITRO STUDIES
Clinical Endocrinology, 1983, 18, 265-275
1.599Citations (PDF)
338Direct adrenergic stimulation of the release of thyrotropin and its subunits from the thyrotrope in vitro.
Endocrinology, 1983, 113, 1244-9
1.938Citations (PDF)
339alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.3.312Citations (PDF)
340The effect of somatostatin on the release of thyrotropin and its subunits from bovine anterior pituitary cells in vitro.
Endocrinology, 1983, 112, 1937-42
1.931Citations (PDF)
341Reduction of plasma immunoreactive somatomedin C during fasting in humans.3.3370Citations (PDF)
342Pure Alpha-Secreting Pituitary Adenomas24.498Citations (PDF)
343Reproductive function during fasting in men.3.3123Citations (PDF)
344Hypothalmic Amenorrhea in Runners of Normal Body Composition0.4113Citations (PDF)
345Decreased Bone Density in Hyperprolactinemic Women24.4364Citations (PDF)